Member Info for itsallamess

Not sure if it's a Finish catarisic not to brag to much? Maybe any of our scandanavian friends here can answer that., but Marku comes across a a modest humble man which makes him unique in the world of AIM CEOs

He never doubted that Traumakine works and as it stands interferon beta is making news in dealing with covid symptoms.

Our day will come with Traumakine but the big story is clevegen.

The CEO is being honest when he said shareholder value in 9 months (or whatever it was)

4 months has passed since then.

I'm here for the long game so happy we are not tossing up and down with the BB full of one lines

Boom
We're gonna be rich
Here it comes
100 bagger
Ect..

However we will boom at some point if not we are alreading booming if you were in at 1.00

what do we know?
1.Drugs gave been eliminated from who solidarity.
2. Interferon is still in the running
3. There are different administrations of interferon being used in the trial. Injection and IV( traumakine)
4. Marku said they donated 2000 treatments
5. We can expect that as drugs are eliminated and interferon is used more then the difference between injection and IV Traumakine will be clearly seen

Exciting times. No doubt faron team are on hand to advise doctors of the use of Traumakine,

Has the SP not moved all morning?

Rns 21st April 2020
Dr Markku Jalkanen, Chief Executive Officer of Faron, said: "We have made significant clinical progress with both our Clevegen and Traumakine projects during the last 12 months and expect both of them to bring significant value for shareholders during the next 8-12 months. Clevegen has shown very promising clinical response in MATINS Part I stage, which we believe will transform into significant opportunity when the study moves to Part II-III expansion stages. Traumakine, on the other hand, has a new corticosteroid-free setting through the global REMAP-CAP study, which we believe is one of the most important intensive care study of the current pandemic environment."

https://www.proactiveinvestors.com/companies/news/168244/faron-has-finnish-patent-application-accepted-168244.html

https://www.proactiveinvestors.co.uk/companies/news/306292/faron-pharmaceuticals-boss-says-patent-protection-is-very-significant-step-6292.html

https://leaderpost.com/diseases-and-conditions/coronavirus/interferon-and-covid-19-we-should-be-stockpiling-says-researcher/wcm/f2a28651-cc13-4423-84a2-eb4e0e1aaa74/

Patent forFreeze dry interferon beta for transport and shelf life. (Imagine the possibilities if need supplied to the world. The royalties alone would add share value)

Patent for IV

Patent for a method of best dermining when and how much interferon should be used

I think the options of all the other drugs they have been trialing are not working

Faron has had 10 years working on ARDS with interferon beta 1a, no one else was interested, then covid came along.

We may not be known by the general public but in the industry they will know about us.

We are still very much the underdog here but as with most movies the rise of the underdog at the end is the most important

Good to see movement here. I had just put these in the bottom draw but looks like they are starting to move up now!

This is what an ace up the other sleeve looks like

https://patents.justia.com/patent/10293030

https://patents.justia.com/patent/10247730

Math, nice article..

SP just shot to 460

Rns 20th November 2017
They went always the same adviser

I think they are all buys

5 5000 trades.
1 marked as a buy 4 sells

However lago are selling on the nas and the SP is pointing up

450

http://www.nasdaqomxnordic.com/aktier/microsite?Instrument=HEX185076&name=Faron%20Pharmaceuticals%20Oy&ISIN=FI4000153309

Another 5000 as a sell

I've never seen lago as the buyer over on the nasdaq, just selling to the scandinavians.

Just shows the money involved.

Clevegen has the potential to make billions

I'd say the 5000 sell is a buy from lago as over on the Naz he is selling